Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
13.01
-0.51 (-3.77%)
At close: Jul 10, 2026, 4:00 PM EDT
13.27
+0.26 (2.00%)
After-hours: Jul 10, 2026, 7:15 PM EDT
Delcath Systems Employees
Delcath Systems had 156 employees as of December 31, 2025. The number of employees increased by 60 or 62.50% compared to the previous year.
Employees
156
Change (1Y)
60
Growth (1Y)
62.50%
Revenue / Employee
$579,750
Profits / Employee
$3,596
Market Cap
449.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 156 | 60 | 62.50% |
| Dec 31, 2024 | 96 | 20 | 26.32% |
| Dec 31, 2023 | 76 | 24 | 46.15% |
| Dec 31, 2022 | 52 | -3 | -5.45% |
| Dec 31, 2021 | 55 | 19 | 52.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,450 |
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,387 |
| Cytek Biosciences | 678 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| Standard BioTools | 389 |
| NeuroPace | 220 |
DCTH News
- 2 days ago - Delcath Systems begins dosing in Phase 2 trial of Hepzato in breast cancer - TheFly
- 2 days ago - Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - Business Wire
- 6 weeks ago - Delcath Systems announces ASCO 2026 investigator initiated trials-in-progress - TheFly
- 6 weeks ago - Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - Business Wire
- 2 months ago - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference - Business Wire
- 2 months ago - Delcath Systems presents new data on M-PHP at ESMO - TheFly
- 2 months ago - Delcath Systems reports Q1 EPS (3c), consensus (9c) - TheFly